Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Biocon Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	532523
ISIN Demat	INE376G01013
Book Value	118.98

NSE Code	BIOCON
Dividend Yield %	0.14
Market Cap	485518.34

P/E	80.91
EPS	4.49
Face Value	5


	BSE		NSE

08-Sep-2025 09:48

Last Price	366.55
Net Change	2.75
% Change	0.76%
Prev.Close	363.80
Open	363.95
High	367.75
Low	362.25
Volume	57237

Last Price	366.80
Net Change	3.1
% Change	0.85%
Prev.Close	363.70
Open	364.00
High	367.85
Low	362.50
Volume	229192

Value	20980222.35
Best Buy	366.30
Best Sell	366.65
Best Quantity	406
Sell Quantity	228
Today's Range	367.75
52-Week High	405.90
52-Week Low	290.80

Value	84067625.6
Best Buy	366.80
Best Sell	366.95
Best Quantity	305
Sell Quantity	6
Today's Range	367.85
52-Week High	406.00
52-Week Low	291.00

Open Price	365.90
High Price	368.85
Low Price	363.85
Last Price	367.00
Prev Close	364.85
Change	2.15
% Change	0.59 %

Average Price	366.97
Underlying Value	366.80
Number of contracts traded	422
Turnover in Rs. Lakhs	3872
Open Interest	39040000.00
Change in O I	17500.00
% Change in O I	0.04 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	406
Price	366.30

Quantity	228
Price	366.65

Best Bid

Best Offer

Quantity	305
Price	366.80

Quantity	6
Price	366.95

Best Bid

Best Offer

Quantity	2500
Price	366.9

Quantity	2500
Price	367.2

Holding Details

Latest Corporate Events

Bonus

1 : 1

12-Jun-19

Book Closure

22-Jul-17

28-Jul-17

Dividend

10 %

04-Jul-25

Company News

05-09-2025

USFDA completes routine c...

05-09-2025

Biocon trades higher on t...

28-08-2025

Biocon’s arm receives ten...

28-08-2025

Biocon inches up as its a...

08-08-2025

Biocon reports 90% fall i...

08-08-2025

Biocon gets nod to enter ...

08-08-2025

Biocon informs about info...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.